Overview

Synchron develops brain-computer interface (BCI) technology that enables individuals, particularly those with severe paralysis, to control digital devices using their thoughts. Their main product involves a minimally invasive endovascular procedure for implanting the BCI, which is similar to placing stents and avoids the need for open brain surgery. This approach makes the technology safer and more accessible for patients with neurological conditions that limit their ability to communicate or move. Unlike competitors, Synchron focuses on a less invasive method of BCI implantation, which can lead to quicker recovery times and a broader patient base. The company's goal is to enhance patient autonomy and social connection by providing them with the ability to interact with technology through thought, ultimately improving their quality of life.

Simplify's Take

What believers are saying

• Collaboration with Nvidia enhances on-device neural processing for more efficient BCI systems.
• Integration with Amazon Alexa opens new markets for BCI technology in smart homes.
• Participation in the BMI Summit positions Synchron as a leader in neurotechnology innovation.

What critics are saying

• Competition from Blackrock Neurotech and Precision Neuroscience may impact Synchron's market share.
• Ethical concerns may arise from handling sensitive brain data with generative AI.
• Dependency on Nvidia's technology could pose risks if Nvidia faces setbacks.

What makes Synchron unique

• Synchron's BCI technology uses a minimally invasive endovascular procedure, unlike open brain surgery.
• The company integrates generative AI to enhance communication for non-verbal patients.
• Synchron's partnership with Amazon allows mind-controlled operation of smart home devices.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$130.6M

Above

Industry Average

Funded Over

5 Rounds

$75,000,000

Series C

Dec 2022

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Above Average

Industry standards

Ind Avg. $50M

$16M

$40M

$50M

$62M

$75M

$100M

View all funding stages